(Press-News.org) Contact information: Jane Finlayson
jane.finlayson@uhn.ca
416-946-2846
University Health Network
Colon cancer researchers target stem cells, discover viable new therapeutic path
(TORONTO, Canada – Dec. 1, 2013) - Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in stem cells that are the root cause of disease, resistance to treatment and relapse. Colorectal cancer is the third leading cause of cancer-related death in the Western world.
"This is the first step toward clinically applying the principles of cancer stem cell biology to control cancer growth and advance the development of durable cures," says principal investigator Dr. John Dick about the findings published online today in Nature Medicine.
He talks about the research in this video - click the link to watch: https://www.youtube.com/watch?v=QK7JquljkBc.
Dr. Dick pioneered the cancer stem cell field by first identifying leukemia stem cells (1994) and colon cancer stem cells (2007). He is also renowned for isolating a human blood stem cell in its purest form – as a single stem cell capable of regenerating the entire blood system – paving the way for clinical use (2011). Dr. Dick holds a Canada Research Chair in Stem Cell Biology and is a Senior Scientist at University Health Network's Princess Margaret Cancer Centre and McEwen Centre for Regenerative Medicine. He is also a Professor in the Department of Molecular Genetics, University of Toronto, and Director of the Cancer Stem Cell Program at the Ontario Institute for Cancer Research.
In pre-clinical experiments, the research team replicated human colon cancer in mice to determine if specifically targeting the stem cells was clinically relevant. First, the researchers identified that the gene BMI-1, already implicated in maintaining stem cells in other cancers, is the pivotal regulator of colon cancer stem cells and drives the cycle of self-renewal, proliferation and cell survival. Next, the team used an existing small-molecule inhibitor to successfully block BMI-1, thus demonstrating the clinical relevance of this approach.
Lead author Dr. Antonija Kreso writes: "Inhibiting a recognized regulator of self-renewal is an effective approach to control tumor growth, providing strong evidence for the clinical relevance of self-renewal as a biological process for therapeutic targeting."
Dr. Dick explains: "When we blocked the BMI-1 pathway, the stem cells were unable to self-renew, which resulted in long-term and irreversible impairment of tumour growth. In other words, the cancer was permanently shut down."
Surgeon-scientist Dr. Catherine O'Brien, senior co-author of the study says: "The clinical potential of this research is exciting because it maps a viable way to develop targeted treatment for colon cancer patients. It is already known that about 65% have the BMI-1 biomarker. With the target identified, and a proven way to tackle it, this knowledge could readily translate into first-in-human trials to provide more personalized cancer medicine."
INFORMATION:
The research was funded by, Genome Canada through the Ontario Genomics Institute, the Ontario Institute for Canada Research and a Premier's Summit Award with funds from the Province of Ontario, the Canadian Institutes of Health Research, the Canada Research Chair Program, the Ontario Ministry of Health and Long-Term Care, and The Princess Margaret Cancer Foundation.
About Princess Margaret Cancer Centre, University Health Network
The Princess Margaret Cancer Centre has achieved an international reputation as a global leader in the fight against cancer and delivering personalized cancer medicine. The Princess Margaret, one of the top five international cancer research centres, is a member of the University Health Network, which also includes Toronto General Hospital, Toronto Western Hospital and Toronto Rehabilitation Institute. All are research hospitals affiliated with the University of Toronto. For more information, go to http://www.theprincessmargaret.ca or http://www.uhn.ca .
Media contact:
Jane Finlayson
Senior Public Affairs Advisor
Princess Margaret Cancer Centre
University Health Network
Phone: 416 946 2846
Email: jane.finlayson@uhn.ca
Colon cancer researchers target stem cells, discover viable new therapeutic path
2013-12-02
ELSE PRESS RELEASES FROM THIS DATE:
'Nanosponge vaccine' fights MRSA toxins
2013-12-02
'Nanosponge vaccine' fights MRSA toxins
Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This "nanosponge vaccine" enabled ...
The mystery of neutron stars heats up
2013-12-02
The mystery of neutron stars heats up
Until now, scientists were pretty sure they knew how the surface of a neutron star – a super dense star that forms when a large star explodes and its core collapses into itself – can heat itself up.
However, research by ...
Human stem cells converted to functional lung cells
2013-12-02
Human stem cells converted to functional lung cells
Possibility of generating lung tissue for transplant using a patient's own cells
NEW YORK, NY — For the first time, scientists have succeeded in transforming human stem cells into functional ...
Imaging shows long-term impact of blast-induced brain injuries in veterans
2013-12-02
Imaging shows long-term impact of blast-induced brain injuries in veterans
CHICAGO – Using a special type of magnetic resonance imaging (MRI), researchers have found that soldiers who suffered mild traumatic brain injury (MTBI) induced by blast exposure ...
Cardiac MRI reveals energy drinks alter heart function
2013-12-02
Cardiac MRI reveals energy drinks alter heart function
CHICAGO – Healthy adults who consumed energy drinks high in caffeine and taurine had significantly increased heart contraction rates one hour later, according to a study presented today at the ...
PRP therapy improves degenerative tendon disease in athletes
2013-12-02
PRP therapy improves degenerative tendon disease in athletes
CHICAGO – Ultrasound-guided delivery of platelet-rich plasma (PRP) improves functionality and reduces recovery time in athletes with degenerative disease in their tendons, according to a study ...
MRI technique reveals low brain iron in ADHD patients
2013-12-02
MRI technique reveals low brain iron in ADHD patients
CHICAGO – Magnetic resonance imaging (MRI) provides a noninvasive way to measure iron levels in the brains of people with attention deficit hyperactivity disorder (ADHD), according to a study being ...
Novel rehabilitation device improves motor skills after stroke
2013-12-02
Novel rehabilitation device improves motor skills after stroke
CHICAGO – Using a novel stroke rehabilitation device that converts an individual's thoughts to electrical impulses to move upper extremities, stroke patients reported improvements in their ...
Special journal issue focuses on imaging screening
2013-12-02
Special journal issue focuses on imaging screening
To be published online Monday, Dec. 2, a special issue of the Journal of the American College of Radiology addresses imaging-based screening and radiology's increasing role in preventive medicine. Topics covered ...
Messy children make better learners
2013-12-02
Messy children make better learners
Study shows toddlers learn words for nonsolids better when getting messy in a highchair
Attention, parents: The messier your child gets while playing with food in the high chair, the more he or she is learning.
Researchers at ...